Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.
Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, Geerling G, Price FW, Remeijer L, Rouse BT, Seitz B, Udaondo P, Meller D, Dua H. Cursiefen C, et al. Among authors: meller d. Br J Ophthalmol. 2012 Jan;96(1):3-9. doi: 10.1136/bjo.2011.204701. Epub 2011 Jun 28. Br J Ophthalmol. 2012. PMID: 21712359
Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study.
Cursiefen C, Viaud E, Bock F, Geudelin B, Ferry A, Kadlecová P, Lévy M, Al Mahmood S, Colin S, Thorin E, Majo F, Frueh B, Wilhelm F, Meyer-Ter-Vehn T, Geerling G, Böhringer D, Reinhard T, Meller D, Pleyer U, Bachmann B, Seitz B. Cursiefen C, et al. Among authors: meller d. Ophthalmology. 2014 Sep;121(9):1683-92. doi: 10.1016/j.ophtha.2014.03.038. Epub 2014 May 6. Ophthalmology. 2014. PMID: 24811963 Free article. Clinical Trial.
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.
Cursiefen C, Bock F, Horn FK, Kruse FE, Seitz B, Borderie V, Früh B, Thiel MA, Wilhelm F, Geudelin B, Descohand I, Steuhl KP, Hahn A, Meller D. Cursiefen C, et al. Among authors: meller d. Ophthalmology. 2009 Sep;116(9):1630-7. doi: 10.1016/j.ophtha.2009.04.016. Epub 2009 Jul 29. Ophthalmology. 2009. PMID: 19643487 Clinical Trial.
[Scientific performance of ophthalmological research institutions in Germany 2018-2020 : Studies, publications, third-party funding and more-The research map of the German Ophthalmological Society (DOG)].
Schaub F, Mele B, Gass P, Ader M, Helbig H, Lagrèze WA, Schlötzer-Schrehardt U, Ueffing M, Cursiefen C; das DOG Forschungslandkartenteam. Schaub F, et al. Ophthalmologie. 2022 Jun;119(6):582-590. doi: 10.1007/s00347-022-01653-z. Epub 2022 May 23. Ophthalmologie. 2022. PMID: 35925367 German.
Expression of MCSP and PRAME in conjunctival melanoma.
Westekemper H, Karimi S, Süsskind D, Anastassiou G, Freistühler M, Meller D, Zeschnigk M, Steuhl KP, Bornfeld N, Schmid KW, Grabellus F. Westekemper H, et al. Among authors: meller d. Br J Ophthalmol. 2010 Oct;94(10):1322-7. doi: 10.1136/bjo.2009.167445. Epub 2010 Aug 30. Br J Ophthalmol. 2010. PMID: 20805128 Free article.
141 results